Dov Pharmaceutical, Inc - DOVP Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Dov Pharmaceutical, Inc - DOVP

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (130)	4/24/2006 7:31:34 PM
From: keokalani'nui	Read Replies (2) of 172

Hey. I avoided a train wreck for once. The company is worth only the Indiplon royalty, less the negative value of current management. Cash less current liabilities less LTD is -$10m. Bicifadine ought to be killed, acute pain model wasn't any good and CBP failure was vs. placebo! The TRI program has nothing to support a value. Ociniplon is dead. Preclinical GABA cpd for GAD and panic? NFW. Not in these guys' hands. If you hear them start to hype this and how excited they are...run for the hills. I would buy dovp at $4. But I could make a case for $8 if Indi was already approved and management resigned and the new guys executed a complete restructuring. That is where ($8)it's trading AF. That is no deal today or until everything about the strategy changes.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next